Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Midsona - Another quarter of margin over momentum

17 juli 2026

<a id="bm-comp-84d3dc90-9299-4406-a848-238a9137b353" name="bm-comp-84d3dc90-9299-4406-a848-238a9137b353" class="BMCustomAnchor"></a><table><tr><td bm-component-id="84d3dc90-9299-4406-a848-238a9137b353" style="vertical-align: top; width:100.000000%;"><ul><li>Adj. EBIT SEK 20m, 7% below ABGSCe SEK 21m</li><li>Continued sales drag from contract manufacturing</li><li>Consensus adj. EBIT revisions likely down low-single-digits</li></ul></td></tr></table><a id="bm-comp-be2f4dc0-4798-427e-be66-3e036ad0e7a7" name="bm-comp-be2f4dc0-4798-427e-be66-3e036ad0e7a7" class="BMCustomAnchor"></a><table><tr><td bm-component-id="be2f4dc0-4798-427e-be66-3e036ad0e7a7" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Growth recovery a story for H2, not Q2</h3><p>The Q2 report was softer than expected on both sales and adj. EBIT. Net sales came in at SEK 870m, 2% below ABGSCe SEK 885m and only 0.6% above last year's SEK 865m. Organic growth was -1.2%, missing ABGSCe's +0.9% by a chunky 2.1pp and only marginally better than the -2.0% comp from Q2'25. Gross margin was the bright spot, in line with ABGSCe at 28.7% reported and 29.3% adjusted, driven by a richer own-brand mix and tight production cost control. However, that didn't carry through to adj. EBIT, which landed at SEK 20m which missed ABGSCe SEK 21m by 7%, with the adj. EBIT margin of 2.3% 0.1pp light of the 2.4% estimate. Opex was a bit elevated as management stepped up marketing behind priority brands. Segment-wise, Nordics was the standout, adj. EBIT of SEK 38m vs. SEK 25m a year ago on 0.5% organic growth. PTP and net profit both beat on lower net financial expenses and 0m in taxes.</p><h3 class="bm-h3">Spain clarity and Risenta integration are the next checkpoints</h3><p>On Risenta, it was consolidated on 1 June and contributed to growth by 1.3%.The Risenta production equipment handover is scheduled for autumn 2026, when the brand is meant to be folded into Midsona's own manufacturing base; until then, only the brand and finished-goods inventory sit on the balance sheet. Midsona has yet to reach an official decision on the long-term plan for operations in Spain, but noted that clarification will be provided during Q3. Marketing investment behind priority own brands is described as "gradually" delivering sales gains and is expected to continue at an elevated sequential level, meaning opex is unlikely to snap back down in H2. On costs, management notes raw material and packaging input prices have been relatively stable but sees no clear picture into year-end, flagging that recent fertiliser price rises could feed through to some raw material and finished-goods costs in H2. Transport and packaging cost pressure tied to the Middle East situation is called "manageable" so far but explicitly ongoing.</p><h3 class="bm-h3">Likely no dramatic changes to consensus estimates</h3><p>The share, which has been very strong YTD, is trading at ~10x NTM EV/EBITA on our unrevised estimates. Our initial understanding of the report as well as a mechanical calculation suggest that consensus' adj. EBIT estimates for '26e-'28e could be negative within a low-single-digit range, however, the lower tax and net financials could lift EPS estimates. The company will host a presentation of the Q2 report at CET 11.00 (<a data-bm-trackable="false" href="https://midsona.events.inderes.com/q2-report-2026/register" target="_blank">link</a>).</p><table id="bm-img-12baf1d6-c59f-4f9e-9594-d891ae49c1d0" class="bm-img-table xslt-img-empty xslt-img-include"><tr><td class="xslt-img-caption">Deviation table</td></tr><tr><td><img bm-img-encrypt="12baf1d6-c59f-4f9e-9594-d891ae49c1d0" bm-img-original-height="412" bm-img-original-width="567" bm-img-svg="image:image_upload/97635_297e484c-8cc2-4743-8da4-089ad889c708.svg" bm-img-width-hint="77.99%" id="bm-id-488fa738-0198-4f8a-a16e-eafd3f80d8d3" src="https://abgsc.bluematrix.com/images/image_upload/97635_297e484c-8cc2-4743-8da4-089ad889c708_567.png" svg="/nas/web/clients/abgsc/images/image_upload/97635_297e484c-8cc2-4743-8da4-089ad889c708.svg" width="567" alt="" title="" /></td></tr><tr><td class="xslt-img-source">Source: ABG Sundal Collier, company data</td></tr></table></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-24 Cavotec - Low-margin legacy orders weigh on Q2 Cavotec Analys
2026-07-24 Cavotec - P&M order momentum sustained Cavotec Analys
2026-07-22 Inission - Strong trend to continue Inission Analys
2026-07-22 SinterCast - Q2 still tough, but we see tailwinds... SinterCast Analys
2026-07-22 Medicover - No symptoms of surprise in Q2 Medicover Analys
2026-07-22 Ework Group - Cautious optimism Ework Group Analys
2026-07-22 Donkey Republic - Helsinki deal offers further de... Donkey Repu.. Analys
2026-07-22 Medicover - In line report, reiterated targets Medicover Analys
2026-07-21 Embellence Group - Broad progress in the DTC stra... Embellence .. Analys
2026-07-21 Eltel - Earnings improve, but less than we hoped Eltel Analys
2026-07-21 CTT Systems - Getting closer to lift-off CTT Systems Analys
2026-07-21 CTT Systems - Better Q2 and OK FY'26 guidance on ... CTT Systems Analys
2026-07-21 Ework Group - Order intake turns the corner Ework Group Analys
2026-07-21 Embellence Group - Sales miss, margins resilient Embellence .. Analys
2026-07-20 Studsvik - DRPS turns, Scandpower awaits H2 Studsvik Analys
2026-07-20 Qliro - NCI miss, but TPV growth still healthy Qliro Analys
2026-07-20 Ferronordic - Positioning itself for a strong H2 Ferronordic Analys
2026-07-19 Prevas - Organic recovery delayed further Prevas Analys
2026-07-19 Ovzon - Ramping costs now for bigger wins later Ovzon Analys
2026-07-19 Alligo - Finland again ahead of plan in a solid Q2 Alligo Analys